Cyclosporine and
Tacrolimus Combo Ophthalmic Solution compounded for dogs combines two immunosuppressive agents in one sterile, oil-based formulation. Veterinarians often prescribe this compounded medication to support ocular comfort and tear production when a suitable commercial alternative is not available.
At Specialty Veterinary Pharmacy, we follow USP <797> sterile compounding standards to ensure quality and precision. Our pharmacists prepare every prescription carefully to maintain consistency and sterility from start to finish. This compounded combination contains Cyclosporine 2% and Tacrolimus 0.03%, packaged in a 5 mL sterile ophthalmic bottle for convenient use.
All ophthalmic preparations at Specialty Veterinary Pharmacy are compounded in a certified cleanroom that exceeds USP <797> sterile standards. Independent organizations inspect this cleanroom twice each year to verify compliance and environmental integrity.
In addition, our team submits each batch for third-party laboratory testing using High-Performance Liquid Chromatography (HPLC) to verify potency and confirm sterility before release. These additional safeguards ensure accuracy and reliability. Therefore, veterinarians can confidently prescribe this compounded combination knowing that every bottle meets our high standards. Detailed test reports are available upon request.
MCT oil serves as a stable and odorless carrier that provides smooth viscosity and even dispersion. Furthermore, it helps improve ocular retention, which allows the active ingredients to remain in contact with the eye surface longer for consistent delivery.
In addition, our continuous quality control, routine testing, and strict compliance procedures ensure that every bottle reflects our commitment to excellence.
By following these guidelines, pet owners help maintain sterility and ensure consistent performance during the 60-day beyond-use period.
In summary, the Cyclosporine and Tacrolimus Combo Ophthalmic Solution provides a sterile, dual-action formulation created for canine patients who need tailored ophthalmic care when commercial options are unavailable.